This inventor holds 26 USPTO granted patents and 5 published patent applications and 20 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Merck Sharp + Dohme Corp., Merck Sharp & Dohme LLC, Merck + Co., Inc.. Active years: 2008-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
21 out of 2,405 
3 out of 72 
1 out of 4,770 
Years Active: 2008-2026
Areas of Expertise:
Title: The Innovative Contributions of Bing Li in Pharmaceutical Sciences
Introduction: Bing Li, based in Towaco, NJ, is a distinguished inventor with a significant portfolio of 23 patents. His innovative work primarily focuses on advancements in pharmaceutical sciences, particularly in the development of insulin analogs and cancer treatment compounds.
Latest Patents: Among his latest contributions are groundbreaking patents that showcase his expertise. One of his significant inventions is a method for creating tyrosine-specific functionalized insulin and insulin analogs. This invention presents processes for synthesizing these compounds using R-3H-1,2,4-triazoline-3,5-(4H)diones (PTAD). Another notable patent is related to tricyclic compounds designed as inhibitors of mutant IDH enzymes. This invention emphasizes the potential for these compounds to aid in the treatment or prevention of cancers linked to mutant IDH enzymes, highlighting their medical importance and application.
Career Highlights: Bing Li has garnered valuable experience at prestigious companies, including Merck Sharp & Dohme Corporation and Merck & Company, Inc., where he has made significant contributions to the field through his research and innovation. His work at these organizations solidifies his role as an influential figure within the pharmaceutical industry.
Collaborations: Throughout his career, Bing Li has collaborated with notable coworkers, including Ihor E. Kopka and Tesfaye Biftu. These partnerships have fostered a collaborative environment, allowing for the exchange of ideas and the advancement of innovative solutions in pharmaceutical research.
Conclusion: With 23 patents to his name and a focus on critical advancements in medicine, Bing Li stands out as a prominent inventor in the pharmaceutical field. His dedicated work in developing functionalized insulin analogs and compounds for cancer treatment demonstrates his commitment to improving health outcomes and contributing to medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile